DISRUPT THERAPEUTICS SL
Company details
- Active NIF/CIF: B44626166
-
-
-
-
Address: CL BALMES NUM.423 P.2 PTA.B (BARCELONA).
-
-
Featured products:

More information on DISRUPT THERAPEUTICS SL
-
BELOW ZERO DEVELOPMENTS SLConsejeroAppointment: 21/02/2025
-
TRESSERRAS SAURI PATRICK.DesconocidoAppointment: 21/02/2025
-
INVEREADY BIOTECH IV SCR SAConsejeroAppointment: 21/02/2025
-
BELOW ZERO DEVELOPMENTS S.L. REPR.143 RRMAdministrador únicoTermination of employment: 21/02/2025
-
BELOW ZERO DEVELOPMENTS S.L. REPR.143 RRMDesconocidoTermination of employment: 21/02/2025
-
BELOW ZERO DEVELOPMENTSPresidenteAppointment: 21/02/2025
-
SECALLRUIZ SARA.DesconocidoAppointment: 21/02/2025
-
ANDREU MARTINEZ DAVID.ConsejeroAppointment: 21/02/2025
-
PINTOS WIDMER DAVID. V-SEC NODesconocidoAppointment: 21/02/2025
-
NOGUERRIBAS ORIOL.ConsejeroAppointment: 21/02/2025
Other information
The CIF of DISRUPT THERAPEUTICS SL is B44626166 and its business status is active. Its economic activity belongs to the CNAE -. Its SIC is -.
DISRUPT THERAPEUTICS SL has Between 1 and 9 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona. It has a total of 11 registration charges. Its last announcement in Borme was published on 21/02/2025 and the latest ordinary annual accounts are from the year 2023.
You can review the contact information of DISRUPT THERAPEUTICS SL such as the phone number, address, or website in the Company Data module.
For more information about DISRUPT THERAPEUTICS SL, you can consult any of our available financial reports, the Annual Accounts of the company, or even check its payment incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about the company name comes from official sources and is updated daily.
Do you want to know more about DISRUPT THERAPEUTICS SL??
Find out more about this company by consulting these reports: